Similar articles

• Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.

  Lichtenstein GR. Lichtenstein GR. Am J Gastroenterol. 2005 Jul;100(7):1433-5. doi: 10.1111/j.1572-0241.2005.50622_1.x. Am J Gastroenterol. 2005. PMID: 15984959 Review. No abstract available.
• Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.

  Hanauer SB. Hanauer SB. Am J Gastroenterol. 2005 Jul;100(7):1438-9. doi: 10.1111/j.1572-0241.2005.50622_3.x. Am J Gastroenterol. 2005. PMID: 15984961 No abstract available.
• Guidelines for treatment with infliximab for Crohn's disease.

  Hommes DW, Oldenburg B, van Bodegraven AA, van Hogezand RA, de Jong DJ, Romberg-Camps MJ, van der Woude J, Dijkstra G; Dutch Initiative on Crohn and Colitis (ICC). Hommes DW, et al. Neth J Med. 2006 Jul-Aug;64(7):219-29. Neth J Med. 2006. PMID: 16929083 Review.
• [Indications and results of infliximab in Crohn's disease].

  Karoui S, Boubaker J, Filali A. Karoui S, et al. Tunis Med. 2004 Dec;82(12):1057-63. Tunis Med. 2004. PMID: 15822505 Review. French.
• The real cost of pediatric Crohn's disease: the role of infliximab in the treatment of pediatric IBD.

  Kay M, Wyllie R. Kay M, et al. Am J Gastroenterol. 2003 Apr;98(4):717-20. doi: 10.1111/j.1572-0241.2003.07396.x. Am J Gastroenterol. 2003. PMID: 12738445 No abstract available.